Abstract Purpose of Review To provide an overview and highlight recent updates in the field
of paraneoplastic neurologic disorders. Recent Findings The prevalence of paraneoplastic …

Targeted therapy and immunotherapy have redefined cancer treatment. While they have
enhanced tumor response and improved survival rates in many cancer types, toxicities …

Abstract Background Immune checkpoint inhibitors (ICIs) represent an effective cancer
immunotherapy yet are associated with immune-related adverse events (irAEs). The aim of …

Objective Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but come
with immune-related adverse events (irAEs) that provide a novel challenge for treating …

ABSTRACT Introduction Immune checkpoint inhibitors (ICIs) represent an innovative
therapeutic approach of oncologic diseases. In Europe, this therapeutic class currently …

Immune checkpoint inhibitors (ICIs) are a revolutionary class of antineoplastic therapy that
restore anti-tumor immunity. Consequences of this enhanced immune response include a …

The emergence of immune checkpoint inhibitors (ICIs) has significantly prolonged the
survival time of cancer patients. However, it may also lead to various immune-related …

Chemotherapy-induced peripheral neuropathy (CIPN) is a major comorbidity of cancer.
Multiple clinical interventions have been studied to effectively treat CIPN, but the results …

Background While immune checkpoint inhibitors (ICIs) have been revolutionary in the
treatment of cancer, their administration has been associated with a variety of immune …

Encephalitis associated with cancer therapies is a rare but serious complication that can
significantly impact patients' quality of life and it requires prompt identification and …